New biphenyl-benzamide derivatives add to potential antibacterial FtsZ inhibitors
Aug. 17, 2022
Researchers from Bioland Laboratory (Guangzhou Regenerative Medicine and Health - Guangdong Laboratory) and the University of Groningen have generated a series of novel biphenyl-benzamides as inhibitors of cell division protein FtsZ with encouraging antibacterial activity.